Nt Vaccine Companies, Vaccine Market "(2 +1) Network Expansion Strategy Research

The 21st century is the biopharmaceutical time of development. China has been one of the biggest vaccine manufacturing countries and the most potential markets in the world, with the annual increasing rate of 16%. The service and the ability of the vaccine distribution companies are still at the primary stage. It is necessary for the distribution companies to build and adjust the distribution channels, improve the cold chain system which is the most important for the quality of vaccine and enhance the professional promotion ability. In order to find the market Niche, the ability of market coverage and management operation have to be enhanced.How to construct and develop the market coverage net of vaccine has been discussed base on the case of NT Pharma in this paper.The current situation of vaccine market in China and the macro environment of NT Pharma have been reviewed. The status of 3 BUs of NT Pharma(distribution, cold chain, sales) has been studied and the development strategy of 3 BUs has also been made. In order to implement the development strategy of "2+1" of NT Pharma, the corresponding measures of finance, information system and stock management are also made base on the practice of NT Pharma.